Blonder Tongue Laboratories Inc. (BDR) Financials Nov 14, 2014, 6:46 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Blonder Tongue Laboratories Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 29.03M 30.51M 26.66M 30.64M 27.87M
Cost of Goods Sold (COGS) incl. D&A 17.76M 18.24M 17.12M 20.63M 18.56M
COGS excluding D&A 17.17M 17.42M 15.98M 19.19M 17.25M
Depreciation & Amortization Expense 590,000 828,000 1.14M 1.44M 1.31M
Depreciation 412,000 352,000 391,000 505,000 453,000
Amortization of Intangibles 178,000 476,000 750,000 933,000 861,000
Gross Income 11.28M 12.27M 9.54M 10.02M 9.31M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 11.07M 10.29M 9.78M 12.51M 11.86M
Research & Development 2.42M 2.51M 2.72M 3.5M 3.37M
Other SG&A 8.65M 7.78M 7.06M 9.01M 8.48M
Other Operating Expense 0 0 0 0 0
Unusual Expense - 0 0 0 0
EBIT after Unusual Expense - 0 0 0 0
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 17,000 7,000 6,000 0 0
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 179,000 199,000 183,000 330,000 277,000
Gross Interest Expense 179,000 199,000 183,000 330,000 277,000
Interest Capitalized 0 0 0 0 0
Pretax Income 42,000 1.79M (411,000) (2.83M) (2.82M)
Income Tax 75,000 0 0 2.33M 0
Income Tax - Current Domestic 0 0 0 3.37M 1.3M
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 404,000 0 0 (1.04M) (1.3M)
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 329,000 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (33,000) 1.79M (411,000) (5.16M) (2.82M)
Minority Interest Expense 0 0 0 0 0
Net Income (33,000) 1.79M (411,000) (5.16M) (2.82M)
Extraordinaries & Discontinued Operations 108,000 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 62,000 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 46,000 0 0 0 0
Net Income After Extraordinaries 75,000 1.79M (411,000) (5.16M) (2.82M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (33,000) 1.79M (411,000) (5.16M) (2.82M)
EPS (Basic) 0.00 0.29 (0.07) (0.83) (0.45)
Basic Shares Outstanding 6.19M 6.19M 6.21M 6.22M 6.22M
EPS (Diluted) 0.00 0.28 (0.07) (0.83) (0.45)
Diluted Shares Outstanding 6.21M 6.29M 6.21M 6.22M 6.22M
EBITDA 794,000 2.81M 907,000 (1.06M) (1.23M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Blonder Tongue Laboratories Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 29.03M 30.51M 26.66M 30.64M 27.87M
Cost of Goods Sold (COGS) incl. D&A 17.76M 18.24M 17.12M 20.63M 18.56M
COGS excluding D&A 17.17M 17.42M 15.98M 19.19M 17.25M
Depreciation & Amortization Expense 590,000 828,000 1.14M 1.44M 1.31M
Depreciation 412,000 352,000 391,000 505,000 453,000
Amortization of Intangibles 178,000 476,000 750,000 933,000 861,000
Gross Income 11.28M 12.27M 9.54M 10.02M 9.31M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 11.07M 10.29M 9.78M 12.51M 11.86M
Research & Development 2.42M 2.51M 2.72M 3.5M 3.37M
Other SG&A 8.65M 7.78M 7.06M 9.01M 8.48M
Other Operating Expense 0 0 0 0 0
Unusual Expense - 0 0 0 0
EBIT after Unusual Expense - 0 0 0 0
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 17,000 7,000 6,000 0 0
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 179,000 199,000 183,000 330,000 277,000
Gross Interest Expense 179,000 199,000 183,000 330,000 277,000
Interest Capitalized 0 0 0 0 0
Pretax Income 42,000 1.79M (411,000) (2.83M) (2.82M)
Income Tax 75,000 0 0 2.33M 0
Income Tax - Current Domestic 0 0 0 3.37M 1.3M
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 404,000 0 0 (1.04M) (1.3M)
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 329,000 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (33,000) 1.79M (411,000) (5.16M) (2.82M)
Minority Interest Expense 0 0 0 0 0
Net Income (33,000) 1.79M (411,000) (5.16M) (2.82M)
Extraordinaries & Discontinued Operations 108,000 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 62,000 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 46,000 0 0 0 0
Net Income After Extraordinaries 75,000 1.79M (411,000) (5.16M) (2.82M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (33,000) 1.79M (411,000) (5.16M) (2.82M)
EPS (Basic) 0.00 0.29 (0.07) (0.83) (0.45)
Basic Shares Outstanding 6.19M 6.19M 6.21M 6.22M 6.22M
EPS (Diluted) 0.00 0.28 (0.07) (0.83) (0.45)
Diluted Shares Outstanding 6.21M 6.29M 6.21M 6.22M 6.22M
EBITDA 794,000 2.81M 907,000 (1.06M) (1.23M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
